Interpreting Hydrogen and Methane Breath Tests in Patients Using GLP-1 Therapies Share The following overview reflects common interpretation questions we encounter when reviewing breath test patterns in patients using GLP-1 therapy
(1) This peptide appears to be naturally present in the bloodstream and has been suggested as a potential element in regulating the growth, development, and apoptosis of vascular endothelial cells
In the subgroup of 34 patients whose HS treatments remained unchanged for 12 months prior to M6, all outcomes demonstrated statistically significant improvement
Duelo, Adriana, et al
Metabolic & GLP-1 Research Semaglutide Long-acting GLP-1 receptor agonist studied for appetite regulation and glucose metabolism in metabolic research models
About the Experts Janese Laster, M.D., is board-certified in internal medicine, gastroenterology, obesity medicine, and nutrition at Georgetown University Hospital